Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GR1X
|
|||
| Drug Name |
Pyrazolodiazepine derivative 1
|
|||
| Synonyms |
PMID26560530-Compound-28
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NATIONAL CANCER CENTER ANYGEN CO., LTD. KIM, Young-Chul LEE, Ju-Yeon KIM, Soo Youl LEE, Byung Il
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H33N5S
|
|||
| Canonical SMILES |
CC(C)CN1CC(NC(=S)C2=NN(C=C21)CC(C)C)CCCCN
|
|||
| InChI |
1S/C18H33N5S/c1-13(2)9-22-11-15(7-5-6-8-19)20-18(24)17-16(22)12-23(21-17)10-14(3)4/h12-15H,5-11,19H2,1-4H3,(H,20,24)/t15-/m0/s1
|
|||
| InChIKey |
SRDGVWFRHBVJPL-HNNXBMFYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.